SCHEMBL22924180

SCHEMBL22924180

Cc1ccc2c(Cl)cn(C)c2c1C(C)(C)Cc1nn(C2CC2)c2c(C(C)(C)C)ccc(F)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22924131 0.67 — —
SCHEMBL22349135 0.66 — —
SCHEMBL26578040 0.66 — —
SCHEMBL22924179 0.63 — —
SCHEMBL22924124 0.61 — —
SCHEMBL22349136 0.58 CYP11B1 (0.39) —
SCHEMBL25724223 0.55 MAPT (0.33) —
SCHEMBL25667872 0.55 NQO2 (0.44) —
SCHEMBL22924127 0.54 NQO2 (0.32) —
SCHEMBL25667950 0.52 ALOX15 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024501-A1 COVALENT INHIBITORS OF KRAS ARAXES PHARMA LLC 2021-01-28 — — US disclosed
Send feedback